Situación actual de la pandemia y el paciente con cáncer

Primer contagio de covid-19 en China fue en noviembre, según prensa - Asia - Internacional - ELTIEMPO.COM. 2020 Mar 13 [cited 2021 May 19]; Available from: https://www.eltiempo.com/mundo/asia/primer-contagio-de-covid-19-en-china-fue-en-noviembre-segun-prensa-472466

Synowiec A, Szczepański A, Barreto-Duran E, Lie LK, Pyrc K. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection. Clin Microbiol Rev [Internet]. 2021 Mar 17;34(2). Available from: https://journals.asm.org/doi/10.1128/CMR.00133-20

Cuervo Maldonado SI. Pandemia de la covid19 y cáncer en el Instituto Nacional de Cancerología –ESE: Cómo actuar pronto y seguro. Rev Colomb Cancerol [Internet]. 2020 Nov 30;24. Available from: https://www.revistacancercol.org/index.php/cancer/article/view/698

Ospina Idárraga JA, Martinez-Cordero H, Idrobo Quintero H, Ortiz Alfaro C, Martínez Correa LM, Garcia JE, et al. Consenso del Grupo de Estudio Latinoamericano de Linfoproliferativos (GELL) para el manejo del Linfoma en estado de Pandemia SARS CoV-2 / COVID 19. Rev Colomb Cancerol [Internet]. 2020 Nov 30;24. Available from: https://www.revistacancercol.org/index.php/cancer/article/view/690

Martinez-Codero H, Martínez LM, Ospina Idárraga JA, Ruiz Argüelles G, Abello Polo V, Peña Ojeda C, et al. Consenso del Grupo Latinoamericano de estudio de Mieloma Múltiple (MM) GELAMM para el manejo del MM en estado de Pandemia SARS CoV-2 / COVID 19. Rev Colomb Cancerol [Internet]. 2020 Nov 30;24. Available from: https://www.revistacancercol.org/index.php/cancer/article/view/656

Ospina-Serrano AV, Abello-Polo V, Patino-Escobar OB, Godoy-Barbosa JI, Gonzalez J, Idrobo H, et al. Recomendaciones para el cuidado de pacientes con cáncer y neoplasias hematológicas en el estado de pandemia COVID-19 en Colombia. Rev Colomb Cancerol [Internet]. 2020 Nov 30;24. Available from: https://www.revistacancercol.org/index.php/cancer/article/view/701

Herazo Maya F, Brugés Maya R, Hincapie Uribe AL, Carvajal Barrera AM, Ospina Serrano AV, Restrepo Ramirez CA, et al. Recomendaciones para el diagnóstico, tratamiento y seguimiento del cáncer de mama durante la pandemia de SARS-Cov-2/COVID-19 en Colombia. Rev Colomb Cancerol [Internet]. 2020 Nov 30;24. Available from: https://www.revistacancercol.org/index.php/cancer/article/view/687

Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol [Internet]. 2020 Mar;21(3):335–7. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1470204520300966

Desai A, Sachdeva S, Parekh T, Desai R. COVID-19 and Cancer: Lessons From a Pooled Meta-Analysis. JCO Glob Oncol [Internet]. 2020 Nov;(6):557–9. Available from: https://ascopubs.org/doi/10.1200/GO.20.00097

Lara Álvarez MÁ, Rogado Revuelta J, Obispo Portero B, Pangua Méndez C, Serrano Montero G, López Alfonso A. Mortalidad por COVID-19 en pacientes con cáncer en un hospital de Madrid durante las primeras 3 semanas de epidemia. Med Clin (Barc) [Internet]. 2020 Sep;155(5):202–4. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0025775320302815

García-Suárez J, de la Cruz J, Cedillo Á, Llamas P, Duarte R, Jiménez-Yuste V, et al. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study. J Hematol Oncol [Internet]. 2020 Dec 8;13(1):133. Available from: https://jhoonline.biomedcentral.com/articles/10.1186/s13045-020-00970-7

Assaad S, Avrillon V, Fournier M-L, Mastroianni B, Russias B, Swalduz A, et al. High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR. Eur J Cancer [Internet]. 2020 Aug;135:251–9. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0959804920303142

Pathania AS, Prathipati P, Abdul BA, Chava S, Katta SS, Gupta SC, et al. COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges. Theranostics [Internet]. 2021;11(2):731–53. Available from: https://www.thno.org/v11p0731.htm

Ospina AV, Bruges R, Mantilla W, Triana I, Ramos P, Aruachan S, et al. Impact of COVID-19 infection on cancer patients experience in Latin American country, ACHOCC-19 Study. Oncologist [Internet]. 2021 Jun 15;onco.13861. Available from: https://onlinelibrary.wiley.com/doi/10.1002/onco.13861

Jammu AS, Chasen MR, Lofters AK, Bhargava R. Systematic rapid living review of the impact of the COVID-19 pandemic on cancer survivors: update to August 27, 2020. Support Care Cancer [Internet]. 2021 Jun 26;29(6):2841–50. Available from: https://link.springer.com/10.1007/s00520-020-05908-w

Moraliyage H, De Silva D, Ranasinghe W, Adikari A, Alahakoon D, Prasad R, et al. Cancer in Lockdown: Impact of the COVID‐19 Pandemic on Patients with Cancer. Oncologist [Internet]. 2021 Feb 26;26(2). Available from: https://onlinelibrary.wiley.com/doi/10.1002/onco.13604

Patt D, Gordan L, Diaz M, Okon T, Grady L, Harmison M, et al. Impact of COVID-19 on Cancer Care: How the Pandemic Is Delaying Cancer Diagnosis and Treatment for American Seniors. JCO Clin Cancer Informatics [Internet]. 2020 Nov;(4):1059–71. Available from: https://ascopubs.org/doi/10.1200/CCI.20.00134

Araujo SEA, Leal A, Centrone AFY, Teich VD, Malheiro DT, Cypriano AS, et al. Impact of COVID-19 pandemic on care of oncological patients: experience of a cancer center in a Latin American pandemic epicenter. Einstein (São Paulo) [Internet]. 2020 Dec 17;19. Available from: https://journal.einstein.br/article/impact-of-covid-19-pandemic-on-care-of-oncological-patients-experience-of-a-cancer-center-in-a-latin-american-pandemic-epicenter/

Addeo A, Friedlaender A. Cancer and COVID-19: Unmasking their ties. Cancer Treat Rev [Internet]. 2020 Aug;88:102041. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0305737220300797

Saavedra Trujillo CH. SECCION VII. Poblaciones especiales. Infectio [Internet]. 2021 Apr 30;25(4):174. Available from: http://revistainfectio.org/index.php/infectio/article/view/971

Han HJ, Nwagwu C, Anyim O, Ekweremadu C, Kim S. COVID-19 and cancer: From basic mechanisms to vaccine development using nanotechnology. Int Immunopharmacol [Internet]. 2021 Jan;90:107247. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1567576920337140

Hall VJ, Foulkes S, Saei A, Andrews N, Oguti B, Charlett A, et al. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study. Lancet [Internet]. 2021 May;397(10286):1725–35. Available from: https://linkinghub.elsevier.com/retrieve/pii/S014067362100790X

Monin L, Laing AG, Muñoz-Ruiz M, McKenzie DR, del Molino del Barrio I, Alaguthurai T, et al. Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study. Lancet Oncol [Internet]. 2021 Jun;22(6):765–78. Available from: